|
|
Taiwan Academic Institutional Repository >
Browse by Author
|
"hsu chiun"
Showing items 96-120 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
| 國立臺灣大學 |
2008-06 |
Outcome of advanced nonsmall cell lung cancer patients receiving gemcitabine and weekly paclitaxel as first-line treatment
|
Lin, Zhong-Zhe; Hsu, Chiun; Chang, Yeun-Chung; Yu, Chong-Jen; Hsu, Chih-Hung; Lin, Chia-Chi; Cheng, Ann-Lii; Yang, Pan-Chyr; Yang, Chih-Hsin; 林宗哲; 許駿; 張允中; 余忠仁; 徐志宏; 林家齊; 鄭安理; 楊泮池; 楊志新 |
| 國立臺灣大學 |
2008 |
Serum Vascular Endothelial Growth Factor/Soluble Vascular Endothelial Growth Factor Receptor 1 Ratio Is an Independent Prognostic Marker in Pancreatic Cancer
|
Chang, Yu-Ting; Chang, Ming-Chu; Wei, Shu-Chen; Tien, Yu-Wen; Hsu, Chiun; Liang, Po-Chin; Tsao, Po-Nien; Jan, I-Shiow; Wong, Jau-Min |
| 國立臺灣大學 |
2008 |
Expression of Mitosis Regulatory Proteins in Biliary Tract Carcinoma: Correlation with Clinico-Pathological Features and Patient Outcome
|
沈盈君; 胡賦強; 鄭永銘; 張玉憲; 林宗哲; 張明志; 許駿; 鄭安理; SHEN, YING-CHUN; HU, FU-CHANG; JENG, YUNG -MING; CHANG, YU-SHIAHN; LIN, ZONG-ZHE; CHANG, MING-CHIH; HSU, CHIUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Comparison of Hypoplastic Myelodysplastic Syndrome (Mds) with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies
|
黃泰中; 柯博升; 唐季祿; 許駿; 陳建源; 蔡偉; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; 田蕙芬; HUANG, TAI-CHUNG; KO, BO-SHENG; TANG, JIH-LUH; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING- CHING; WANG, CHIU-HWA; TIEN, HWEI-FANG |
| 國立臺灣大學 |
2008 |
A Revisit of Prophylactic Lamivudine for Chemotherapy-Associated Hepatitis B Reactivation in Non-Hodgkin's Lymphoma: A Randomized Trial
|
許駿; 熊昭; 蘇益仁; 黃偉修; 張明志; 李啟誠; 巫宏博; 田蕙芬; 趙祖怡; 鄭安理; 陳培哲; HSU, CHIUN; HSIUNG, CHAO A.; SU, IH-JEN; HWANG, WEI-SHOU; CHANG, MING-CHIH; LI, CHI-CHENG; WU, HUNG-BO; TIEN, HWEI-FANG; CHAO, TSU-YI; CHENG, ANN -LII; CHEN, PEI-JER |
| 國立臺灣大學 |
2008 |
Expression of the Nuclear Factor Kappa B (Nfkb) P50/P65 Proteins in Hepatocellular Carcinoma (Hcc): Lack of Predictive Value for Response to Thalidomide Treatment
|
許駿; 陳立宗; 趙毅; 沈盈君; 鄭安理; HSU, CHIUN; CHEN, LI-TZONG; CHAO, YEE; SHEN, YING-CHUN; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Forkhead Box Transcription Factor Foxo3a Suppresses Estrogen-Dependent Breast Cancer Cell Proliferation and Tumorigenesis
|
鄭建睿; 許駿; CHENG, CHIEN-JUI; HSU, CHIUN |
| 國立臺灣大學 |
2008 |
Gemcitabine Plus Conventional-Dose Epirubicin Versus Gemcitabine Plus Cisplatin as First-Line Chemotherapy for Stage Iiib/Iv Non-Small Cell Lung Carcinoma-a Randomized Phase Ii Trial
|
許駿; 郭頌鑫; 胡賦强; 鄭安理; 施金元; 余忠仁; 林家齊; 楊泮池; 楊志新; HSU, CHIUN; KUO, SUNG-HSIN; HU, FU-CHANG; CHENG, ANN-LII; SHIH, JIN-YUAN; YU, CHONG-JEN; LIN, CHIA-CHI; YANG, PAN-CHYR; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2008 |
Geographic Difference in Clinical Trial Practice for Advanced Hepatocellular Carcinoma (Hcc): Implications on Trial Design of Global Scale
|
許駿; 沈盈君; 胡賦强; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HU, FU-CHANG; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Imaging Adjustment with Dosimetric Verification of Cone-Beam Ct in Head and Neck Cancer Patient
|
許駿; 吳簡坤; 趙曉玲; 王駿瑋; 蔡巧琳; 成佳憲; HSU, CHIUN; WU, JIAN-KUEN; CHAO, HSIAO-LING; WANG, CHUN-WEI; TSAI, CHIAO-LING; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Phase Ii Study of Sorafenib Plus Tegafur/Uracil (Uft) in Patients with Advanced Hepatocellular Carcinoma (Hcc)
|
沈盈君; 邵幼雲; 徐志宏; 許駿; 林宗哲; 陳培哲; 丁雅慧; 鄭安理; SHEN, YING-CHUN; SHAO, YU-YUN; HSU, CHIH-HUNG; HSU, CHIUN; LIN, ZONG-ZHE; CHEN, PEI-JER; DING, YEA-HUI; CHENG, ANN-LII |
| 國立臺灣大學 |
2008 |
Predictors of Toxicity of Weekly Docetaxel in Chemotherapy-Treated Non- Small Cell Lung Cancers
|
陳若白; 羅英; 余忠仁; 許駿; 施金元; 楊志新; CHEN, JO-PAI; LO, YIN; YU, CHONG-JEN; HSU, CHIUN; SHIH, JIN-YUAN; YANG, CHIH-HSIN; YANG, CHIH- HSIN |
| 國立臺灣大學 |
2008 |
Reconstructed Volume Loss on Cone-Beam Ct Images of Moving Targets
|
趙曉玲; 許駿; 吳簡坤; 成佳憲; CHAO, HSIAO-LING; HSU, CHIUN; WU, JIAN-KUEN; CHENG, JASON CHIA-HSIEN |
| 國立臺灣大學 |
2008 |
Weekly Cisplatin, Infusional High-Dose 5-Fluorouracil and Leucovorin for Advanced, Recurrent and Metastatic Cervical Carcinoma
|
蕭聖謀; 陳祈安; 許駿; 林鶴雄; 謝長堯; 魏凌鴻; HSIAO, SHENG-MOU; CHEN, CHI-AN; HSU, CHIUN; LIN, HO-HSIUNG; HSIEH, CHANG-YAO; WEI, LIN-HUNG |
| 國立臺灣大學 |
2008 |
Sorafenib Overcomes Bortezomib Resistance of Hepatocellular Carcinoma Cells by down-Regulating Phospho-Akt and Bcl-2
|
陳昆鋒; 許駿; 徐志宏; 葉培彥; 李水盛; 陳培哲; 鄭安理; CHEN, KUEN-FENG; HSU, CHIUN; HSU, CHIH-HUNG; YEH, PEI-YEN; LEE, SHOEI-SHENG; CHEN, PEI-JER; CHENG, ANN-LII |
| 國立臺灣大學 |
2007 |
Comparison of Hypoplastic Myelodysplastic Syndrome with Normo-/ Hypercellular Mds by International Prognostic Scoring System, Cytogenetic and Genetic Studies
|
田蕙芬; 柯博升; 許駿; 陳建源; 蔡偉; 唐季祿; 黃聖懿; 姚明; 陳耀昌; 沈銘鏡; 王秋華; TIEN, HWEI-FANG; KO, PO-SHENG; HSU, CHIUN; CHEN, CHIEN-YUAN; TSAY, WOEI; TANG, JIH- LUH; HUANG, SHANG-YI; YAO, MING; CHEN, YAO-CHANG; SHEN, MING-CHING; WANG, CHIU-HWA |
| 國立臺灣大學 |
2007 |
Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma
|
Chang, Yu-Ting; Hsu, Chiun; Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min |
| 國立臺灣大學 |
2007 |
Dynamic Mri Signals in the Second Week of Radiotherapy Relate to Treatment Outcomes of Hepatocellular Carcinoma: A Preliminary Result
|
梁博欽; 常慧如; 許駿; 曾鑠鑠; 施庭芳; 劉滄梧; LIANG, PO-CHIN; CHANG, HUI-JU; HSU, CHIUN; TSENG, SHUO-SHUO; SHIH, TIFFANY TING-FANG; LIU, TSANG-WU |
| 國立臺灣大學 |
2007 |
Arsenic Trioxide in Patients with Hepatocellular Carcinoma: A Phase Ii Trial
|
林家齊; 許駿; 徐志宏; 許瑋玲; 鄭安理; 楊志新; LIN, CHIA-CHI; HSU, CHIUN; HSU, CHIH-HUNG; HSU, WEI-LING; CHENG, ANN-LII; YANG, CHIH-HSIN |
| 國立臺灣大學 |
2007 |
A Phase Ii Trial of Weekly Paclitaxel and High-Dose 5-Fluorouracil Plus Leucovorin in Patients with Chemotherapy-Pretreated Metastatic Breast Cancer
|
林家齊; 鄭安理; 徐志宏; 盧彥伸; 許駿; 葉坤輝; 吳貞瑤; 黃俊升; 楊志新; LIN, CHIA-CHI; CHENG, ANN-LII; HSU, CHIH-HUNG; LU, YEN-SHEN; HSU, CHIUN; YEH, KUN-HUEI; WU, CHEN-YAO; HUANG, CHIUN-SHENG; YANG, CHIH-HSIN |
| 臺大學術典藏 |
2007 |
Expression of the caudal-type homeodomain transcription factor CDX2 is related to clinical outcome in biliary tract carcinoma
|
Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min; Chang, Yu-Ting; Hsu, Chiun; Chang, Yu-Ting; Hsu, Chiun; Jeng, Yung-Ming; Chang, Ming-Chu; Wei, Shu-Chen; Wong, Jau-Min |
| 國立臺灣大學 |
2006 |
PHASE I STUDY OF BIWEEKLY GEMCITABINE FOLLOWED BY OXALIPLATIN AND SIMPLIFIED 48-H INFUSION OF FLUOROURACIL/LEUCOVORIN FOR ADVANCED PANCREATIC CANCER
|
CHANG, HUI-JU; WANG, CHUAN-CHENG; CHENG, ANN-LII; HSU, CHIUN; LU, YEN-SHEN; CHANG, MING-CHU; LIN, JAW-TOWN; WANG, HSIU-PO; LIU, TSANG-WU; CHANG, JANG-YANG; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG; 張慧如; 王全正; 鄭安理; 許駿; 盧彥伸; 章明珠; 林肇堂; 王秀伯; 劉滄梧; 張俊彥; 彭汪嘉康; 陳立宗 |
| 國立臺灣大學 |
2006 |
Clinical Implication of Blood Levels of B-Type Natriuretic Peptide in Pediatric Patients on Mechanical Circulatory Support
|
黃書健; 吳恩婷; 柯文哲; 賴凌平; 許駿; 張重義; 邱英世; 王水深; 吳美環; 林芳郁; 陳益祥; HUANG, SHU-CHIEN; WU, EN-TING; KO, WEN-JE; LAI, LING-PING; HSU, CHIUN; CHANG, CHUNG-I; CHIU, ING-SH; WANG, SHOEI-SHEN; WU, MEI-HWAN; LIN, FANG-YUE; CHEN, YIH-SHARNG |
| 國立臺灣大學 |
2006 |
Phase I-Ii Trial of Weekly Gemcitabine Plus High-Dose 5-Fluorouracil and Leucovorin in Advanced Pancreatic Cancer
|
鄭安理; 許駿; 徐志宏; 劉滄梧; 張俊彥; 詹昌明; 趙毅; 尤維蘭; 彭汪嘉康; 陳立宗; CHENG, ANN-LII; HSU, CHIUN; HSU, CHIH-HUNG; LIU, TSANG-WU; CHANG, JANG-YANG; JAN, CHANG-MING; CHAO, YEE; YU, WEI-LAN; WHANG-PENG, JACQUELINE; CHEN, LI-TZONG |
| 國立臺灣大學 |
2006 |
Difference in the Incidence Trend of Nasopharyngeal and Oropharyngeal Carcinomas in Taiwan: Implication from Age-Period-Cohort Analysis
|
許駿; 沈盈君; 洪瑞隆; 張啟仁; 鄭安理; HSU, CHIUN; SHEN, YING-CHUN; HONG, RUEY-LONG; CHANG, CHEE-JEN; CHENG, ANN-LII |
Showing items 96-120 of 149 (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page
|
